Thymosin Alpha-1 10mg

Thymosin Alpha-1 10 mg is a lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

Product Overview

Thymosin Alpha-1 is a synthetic peptide research compound investigated in experimental models involving peptide signalling, immune-associated molecular pathways and cellular regulatory mechanisms.

This preparation is supplied as a nominal 10 mg lyophilized research material. Independent testing by Liquilabs s.r.o. Czechia confirmed an assay content of 10.18 ± 0.05 mg and purity of 99.0 ± 0.5%.

Additional analytical testing included peptide identity verification, molecular ion mass identification, bacterial endotoxin analysis, microbiological assessment and elemental impurity screening, providing comprehensive batch-specific documentation.

Peptide Overview

Thymosin Alpha-1 is a 28-amino-acid peptide studied in laboratory research involving molecular signalling and immune-associated cellular processes.

Its defined peptide structure makes it relevant to controlled investigations examining peptide interactions, biochemical pathways and intracellular regulatory systems.

Chromatographic analysis and mass spectrometry provide analytical methods for characterising peptide identity, purity and assay content.

Historical Background and Scientific Context

Thymosin Alpha-1 originates from scientific investigations into thymus-associated peptides and their involvement in biological signalling processes.

Research has examined this peptide in experimental models involving immune-associated molecular signalling, cellular communication and biochemical regulation.

Advances in peptide synthesis, chromatography and mass spectrometry have improved the analytical characterisation of Thymosin Alpha-1 for controlled scientific investigation.

Mechanistic Focus in Research

Within controlled laboratory environments, Thymosin Alpha-1 may be investigated in relation to peptide-mediated signalling and immune-associated molecular pathways.

Research topics include:

• Peptide-mediated molecular signalling
• Immune-associated cellular pathways
• Intracellular regulatory mechanisms
• Peptide interaction research
• Biochemical pathway analysis
• Controlled in vitro peptide investigations

These areas represent scientific research interests and do not establish biological activity or therapeutic effectiveness for the tested material.

Analytical Verification (COA)

Independent analytical testing was performed by Liquilabs s.r.o. Czechia to characterise peptide identity, assay content, purity and additional laboratory quality parameters.

Batch: GF-THYMA120-B243
Sample: LYO-1009
COA Publication Date: 11 October 2026

• Assay Content: 10.18 ± 0.05 mg
• Purity: 99.0 ± 0.5%
• Identification by Spectrum: 945 ± 5
• Identification by Retention Time: 0.999 ± 0.005
• Molecular Ion Mass: 3108 ± 1 Da
• Bacterial Endotoxins: 0.143 ± 0.003 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g
• Elemental Impurities: Arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt each below 0.001 ppm

The measured assay content was approximately 1.8% above the nominal 10 mg quantity. Chromatographic analysis reported 99.0% purity, while spectrum identification, retention time analysis and mass spectrometry provided additional analytical identity parameters.

Bacterial endotoxin testing reported 0.143 EU/mg, within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Both microbiological counts were reported as 0 CFU/g.

These results provide transparent batch-specific analytical documentation but do not establish sterility or suitability for administration.

Research Applications

Thymosin Alpha-1 may be utilised in controlled laboratory models investigating:

• Peptide chemistry and molecular characterisation
• Immune-associated signalling pathways
• Cellular communication mechanisms
• Biochemical regulatory processes
• Comparative peptide investigations
• In vitro molecular research

All applications are intended exclusively for scientific investigation under controlled laboratory conditions.

Grail Formula Quality

Grail Formula supports research material characterisation through independent analytical verification and transparent batch-specific Certificates of Analysis.

For this production batch, testing included assay determination, purity assessment, peptide identity verification, molecular ion mass identification, bacterial endotoxin analysis, microbiological testing and elemental impurity screening.

This approach provides researchers with detailed analytical information relating directly to the tested production batch.

When You Choose Grail Formula

Researchers selecting Grail Formula receive peptide research materials supported by independent third-party analytical documentation.

Thymosin Alpha-1 10 mg batch GF-THYMA120-B243 was analysed by Liquilabs s.r.o. Czechia, with its Certificate of Analysis published on 11 October 2026.

The analytical report provides traceable laboratory results supporting research material assessment and controlled scientific investigation.

Research Use Limitation

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use.

• Product: Thymosin Alpha-1 10 mg
• Brand: Grail Formula
• Form: Lyophilized research peptide
• Independent Laboratory: Liquilabs s.r.o. Czechia
• Batch Number: GF-THYMA120-B243
• Sample Identification: LYO-1009
• Assay Content: 10.18 ± 0.05 mg
• Purity: 99.0 ± 0.5%
• Spectrum Identification: 945 ± 5
• Retention Time Identification: 0.999 ± 0.005
• Molecular Ion Mass: 3108 ± 1 Da
• Bacterial Endotoxins: 0.143 ± 0.003 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g
• Elemental Impurities: As, Cd, Hg, Pb, Ni, V and Co each below 0.001 ppm
• COA Publication Date: 11 October 2026
• Research Limitation: For laboratory and in vitro research only; not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.